The McCabe Research Group is led by the internationally recognized health economist, Dr. Christopher McCabe. Dr. McCabe has a substantial record of applied and methodological research applied health research in both Europe and North America. The focus of Dr. McCabe’s research is providing evidence to support health care decision makers to make the best use of our limited health care resources. By engaging with policy makers, clinician and patient communities; our research aims to encourage the development of high value health care and disinvestment from technologies whose cost exceeds the benefits they provide.
Professor Christopher McCabe is a health economist and Principal Investigator on the Genome Canada funded PACEOMICS project, as well as the recently established Precision Medicine Policy Network. He also has a long track record of policy research on Orphan Drugs and is currently the Co-Principal Investigator of a CIHR Emerging Team grant looking at innovative solutions for the reimbursement of treatments for rare diseases. His primary research interest is in the development of efficient research and development processes for biotherapies and devices in the context of value based reimbursement market access hurdles. He has published over 150 hundred peer reviewed papers, book chapters and monographs. He holds a Capital Health Endowed Research Chair at the University of Alberta, having previously held Chairs at the Universities of Leeds, Warwick and Sheffield. He continues to hold a Visiting Chair at the University of Leeds. He has acted as a consultant for public and private sector organizations in Europe, North America and Australasia; most notably with NICE in the United Kingdom, with whom he had various roles between 2003 and 2011.